Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
3-((3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-6-oxo-17-((R)-2,6,6-trimethyltetrahydro-2H-pyran-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-3-yloxy)-1,2,4-oxadiazol-5(4H)-one
ID: ALA4251500
PubChem CID: 145984126
Max Phase: Preclinical
Molecular Formula: C32H50N2O6
Molecular Weight: 558.76
Molecule Type: Small molecule
This compound is available for customization.
Associated Items: